Bioenergetics and intermuscular fat in chronic obstructive pulmonary disease-associated quadriceps weakness

Muscle and Nerve

Volumn 51, Issue 2, 2015, Pages 214-221

  Shields, Gregory Samuel ^a   Coissi, Graziele S ^b   Jimenez Royo, Pilar ^c   Gambarota, Giulio ^a   Dimber, Rahul ^a   Hopkinson, Nicholas S ^b   Matthews, Paul M ^a,c,d   Brown, Andrew P ^a   Polkey, Michael I ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

31P MRS; Adipose tissue; Anaerobic metabolism; Intermuscular fat; Skeletal muscle

Indexed keywords

CREATINE PHOSPHATE; FAT; PHOSPHORUS;

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENERGY METABOLISM; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMAGE PROCESSING; MALE; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PH; PHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

AGED; ENERGY METABOLISM; EXERCISE; FATS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROGEN-ION CONCENTRATION; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84920874600     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24289     Document Type: Article

References (50)

1. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-120.
2. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-813.
3. Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 2005;128:3838-3845.
4. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40:1115-1122.
5. Natanek SA, Gosker HR, Slot IG, Marsh GS, Hopkinson NS, Man WD, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve 2013;48:488-497.
6. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990;3:192-196.
7. Swallow EB, Gosker HR, Ward KA, Moore AJ, Dayer MJ, Hopkinson NS, et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 2007;103:739-746.
8. Jobin J, Maltais F, Doyon JF, LeBlanc P, Simard PM, Simard AA, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 1998;18:432-437.
9. Patel MS, Mohan D, Andersson YM, Baz M, Kon SS, Canavan JL, et al. Phenotypic characteristics associated with reduced short physical performance battery score in chronic obstructive pulmonary disease. Chest in press doi: 10.1378/chest.13-1398. [Epub ahead of print].
10. Steiner MC, Evans R, Deacon SJ, Singh SJ, Patel P, Fox J, et al. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax 2005;60:932-936.
11. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-293.
12. Polkey MI, Hawkins P, Kyroussis D, Ellum SG, Sherwood R, Moxham J. Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD. Thorax 2000;55:547-549.
13. Hawkins P, Johnson LC, Nikoletou D, Hamnegard CH, Sherwood R, Polkey MI, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 2002;57:853-859.
14. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:9-18.
15. Chance B, Leigh JS Jr, Clark BJ, Maris J, Kent J, Nioka S, et al. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci USA 1985;82:8384-8388.
16. Taylor DJ, Bore PJ, Styles P, Gadian DG, Radda GK. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med 1983;1:77-94.
17. Lanza IR, Bhagra S, Nair KS, Port JD. Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements. J Magn Res Imaging 2011;34:1143-1150.
18. Kutsuzawa T, Shioya S, Kurita D, Haida M, Ohta Y, Yamabayashi H. Muscle energy metabolim and nutritional status in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:647-652.
19. Kutsuzawa T, Shioya S, Kurita D, Haida M, Ohta Y, Yamabayashi H. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis 1992;146:1019-1024.
20. Payen JF, Wuyam B, Levy P, Reutenauer H, Stieglitz P, Paramelle B, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993;147:592-598.
21. Hamaoka T, Tatsumi K, Saito Y, Arai Y, Horie Y, Masuyama S, et al. Metabolic activity in skeletal muscles of patients with non-hypoxaemic chronic obstructive pulmonary disease studied by 31P-magnetic resonance spectroscopy. Respirology 2005;10:164-170.
22. McKeough ZJ, Alison JA, Bye PT, Trenell MI, Sachinwalla T, Thompson CH, et al. Exercise capacity and quadriceps muscle metabolism following training in subjects with COPD. Respir Med 2006;100:1817-1825.
23. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726-1734.
24. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001;17:939-945.
25. Hernandez N, Orozco-Levi M, Belalcazar V, Pasto M, Minguella J, Broquetas JM, et al. Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 2003;134:219-229.
26. Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003;58:665-669.
27. Edwards RHT, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci 1977;52:283-290.
28. ATS statement:guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
29. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-631.
30. Ide T, Nichols DG, Buck JR, Eleff SM, Shungu DC, Robotham JL, et al. Effect of aminophylline on high-energy phosphate metabolism and fatigue in the diaphragm. Anesthesiology 1995;83:557-567.
31. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
32. Vanderthommen M, Duteil S, Wary C, Raynaud JS, Leroy-Willig A, Crielaard JM, et al. A comparison of voluntary and electrically induced contractions by interleaved 1H- and 31P-NMRS in humans. J Appl Physiol 2003;94:1012-1024.
33. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Res Med 1984;1:307-315.
34. Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004;79:874-880.
35. Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH. Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest 1995;108:182-189.
36. 2 with small muscle mass exercise. Am J Respir Crit Care Med 2004;169:89-96.
37. Wuyam B, Payen JF, Levy P, Bensaidane H, Reutenauer H, Le Bas JF, et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 1992;5:157-162.
38. Mannix ET, Boska MD, Galassetti P, Burton G, Manfredi F, Farber MO. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. J Appl Physiol 1995;78:2218-2227.
39. Man WD, Hopkinson NS, Harraf F, Nikoletou D, Polkey MI, Moxham J. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax 2005;60:718-722.
40. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012;106:522-530.
41. Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Am J Physiol Regul Integr Comp Physiol 2011;300:R1142-1147.
42. Steiner MC, Roubenoff R, Tal-Singer R, Polkey MI. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease:a translational review. Thorax 2012;67:1102-1109.
43. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-977.
44. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 2007;85:377-384.
45. Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 2001;90:2157-2165.
46. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol Series A Biol Sci Med Sci 2005;60:324-333.
47. HajGhanbari B, Hamarneh G, Changizi N, Ward AD, Reid WD. MRI-based 3D shape analysis of thigh muscles patients with chronic obstructive pulmonary disease versus healthy adults. Acad Radiol 2011;18:155-166.
48. Mathur S, Takai KP, Macintyre DL, Reid D. Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease. Phys Ther 2008;88:219-230.
49. Roig M, Eng JJ, MacIntyre DL, Road JD, Reid WD. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prevent 2011;31:120-124.
50. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008;134:405-415.